U.S. Biodefense Industry Research 2024-2030: Focus on Anthrax, Small Pox, Botulism, & Radiation/Nuclear
July 24, 2024 10:23 ET
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "U.S. Biodefense Market Size, Share & Trends Analysis Report by Product (Anthrax, Small Pox, Botulism, Radiation/nuclear), and Segment Forecasts,...
Paving the Way for Advanced AI Biosecurity Screening for Australia's Agriculture Sector
October 03, 2023 20:03 ET
|
Trellis Data
BRISBANE, Australia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trellis Data, a leading provider of AI-driven solutions, together with the Australian Department of Agriculture, Fisheries and Forestry (the...
BTG Pharmaceuticals, a SERB company, to present data on ricin antidote development programme at the North American Congress of Clinical Toxicology
September 21, 2023 06:42 ET
|
BTG Specialty Pharmaceuticals
West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as...
Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants
January 17, 2023 08:00 ET
|
XWELL, Inc.
BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease...
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
August 15, 2022 09:00 ET
|
XpresSpa Group, Inc.
BOSTON and NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they will continue to support the Centers for Disease Control and...
Biodefense Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
June 06, 2022 05:00 ET
|
Graphical Research
Pune, India, June 06, 2022 (GLOBE NEWSWIRE) -- The global biodefense market size is poised to grow at a significant CAGR during the forecast period, owing to the rising incidence of infectious...
Synthetic Biology Market to Reach USD 32.73 Billion by 2028 - Increasing Applications of Synthetic Biological Products is Expected to Drive the Synthetic Biology Market - Vantage Market Research
February 07, 2022 02:45 ET
|
Vantage Market Research
WASHINGTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Synthetic biology is an area for scientific research that involves redesigning organisms for useful purposes by engineering them to have new abilities....
Relay Medical and Fio Report on Testing Success at Pearson Airport and the Significance of What Has Been Accomplished
May 06, 2021 17:00 ET
|
Relay Medical Corp.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”), through their joint venture company...
Biosurveillance Market To Reach USD 5.62 Billion By 2027 | Reports and Data
May 07, 2020 17:00 ET
|
Reports and Data
New York, May 07, 2020 (GLOBE NEWSWIRE) -- The Global Biosurveillance market is forecast to reach USD 5.62 Billion by 2027, according to a new report by Reports and Data. The recent H1N1 Influenza...
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries
April 12, 2018 06:30 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., April 12, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market...